119 related articles for article (PubMed ID: 16871602)
1. Subtype selective tetracycline agonists and their application for a two-stage regulatory system.
Berens C; Lochner S; Löber S; Usai I; Schmidt A; Drueppel L; Hillen W; Gmeiner P
Chembiochem; 2006 Sep; 7(9):1320-4. PubMed ID: 16871602
[No Abstract] [Full Text] [Related]
2. Transactivator mutants with altered effector specificity allow selective regulation of two genes by tetracycline variants.
Krueger C; Schmidt A; Danke C; Hillen W; Berens C
Gene; 2004 Apr; 331():125-31. PubMed ID: 15094198
[TBL] [Abstract][Full Text] [Related]
3. The roles of hydrogen bonding and sterics in RNA interference.
Somoza A; Chelliserrykattil J; Kool ET
Angew Chem Int Ed Engl; 2006 Jul; 45(30):4994-7. PubMed ID: 16802393
[No Abstract] [Full Text] [Related]
4. Transcriptional activation by tetracyclines in mammalian cells.
Gossen M; Freundlieb S; Bender G; Müller G; Hillen W; Bujard H
Science; 1995 Jun; 268(5218):1766-9. PubMed ID: 7792603
[TBL] [Abstract][Full Text] [Related]
5. Tight regulation of transgene expression by tetracycline-dependent activator and repressor in brain.
Uchida S; Sakai S; Furuichi T; Hosoda H; Toyota K; Ishii T; Kitamoto A; Sekine M; Koike K; Masushige S; Murphy G; Silva AJ; Kida S
Genes Brain Behav; 2006 Feb; 5(1):96-106. PubMed ID: 16436193
[TBL] [Abstract][Full Text] [Related]
6. Tetracycline-regulated expression implemented through transcriptional activation combined with proximal and distal repression.
Peacock RW; Sullivan KA; Wang CL
ACS Synth Biol; 2012 May; 1(5):156-62. PubMed ID: 23651153
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline- and tetracycline-regulated transcriptional silencer enhance the expression level and transactivating performance of rtTA.
Lai JF; Cheng HY; Cheng TL; Lin YY; Chen LC; Lin MT; Jou TS
J Gene Med; 2004 Dec; 6(12):1403-13. PubMed ID: 15523716
[TBL] [Abstract][Full Text] [Related]
8. Controlled secretion of beta-endorphin from human embryonic kidney cells carrying a Tet-on-beta-endorphin fusion gene.
Saitoh Y; Eguchi Y; Nakahira R; Yasuda K; Moriuchi S; Yoshimine T; Boileau G
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):151-5. PubMed ID: 14969748
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of tTS-H4: a novel transcriptional repressor that is compatible with the reverse tetracycline-controlled TET-ON system.
Bockamp E; Christel C; Hameyer D; Khobta A; Maringer M; Reis M; Heck R; Cabezas-Wallscheid N; Epe B; Oesch-Bartlomowicz B; Kaina B; Schmitt S; Eshkind L
J Gene Med; 2007 Apr; 9(4):308-18. PubMed ID: 17330923
[TBL] [Abstract][Full Text] [Related]
10. Increased -1 ribosomal frameshifting efficiency by yeast prion-like phenotype [PSI+].
Park HJ; Park SJ; Oh DB; Lee S; Kim YG
FEBS Lett; 2009 Feb; 583(4):665-9. PubMed ID: 19166852
[TBL] [Abstract][Full Text] [Related]
11. A one-step approach to obtain cell clones expressing tetracycline-responsive transactivators.
Muñoz I; Gómez A; Zanuy S; Carrillo M
Anal Biochem; 2004 Aug; 331(1):153-60. PubMed ID: 15246008
[TBL] [Abstract][Full Text] [Related]
12. A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain.
Akagi K; Kanai M; Saya H; Kozu T; Berns A
Nucleic Acids Res; 2001 Feb; 29(4):E23. PubMed ID: 11160943
[TBL] [Abstract][Full Text] [Related]
13. Modulation of myosin A expression by a newly established tetracycline repressor-based inducible system in Toxoplasma gondii.
Meissner M; Brecht S; Bujard H; Soldati D
Nucleic Acids Res; 2001 Nov; 29(22):E115. PubMed ID: 11713335
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects.
Ray P; Tsien R; Gambhir SS
Cancer Res; 2007 Apr; 67(7):3085-93. PubMed ID: 17409415
[TBL] [Abstract][Full Text] [Related]
15. Tet system in the brain: transgenic rats and lentiviral vectors approach.
Konopka W; Duniec K; Klejman A; Wawrzyniak M; Owczarek D; Gawrys L; Maleszewski M; Mallet J; Kaczmarek L
Genesis; 2009 Apr; 47(4):274-80. PubMed ID: 19241392
[TBL] [Abstract][Full Text] [Related]
16. A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays.
Hampf M; Gossen M
Anal Biochem; 2006 Sep; 356(1):94-9. PubMed ID: 16750160
[TBL] [Abstract][Full Text] [Related]
17. Protein-DNA interaction-based detection of small molecules by employing Renilla luciferase fusion protein: quantitative and generic measurement of tetracyclines with a Renilla luciferase-tagged Tet repressor protein.
Pellinen T; Rytkonen K; Ristiniemi N; Karp M; Lamminmaki U
Anal Biochem; 2006 Nov; 358(2):301-3. PubMed ID: 16970903
[No Abstract] [Full Text] [Related]
18. Efficacy of tetracycline-controlled gene expression is influenced by cell type: commentary.
Gossen M; Bujard H
Biotechniques; 1995 Aug; 19(2):213-6; discussion 216-7. PubMed ID: 8527141
[No Abstract] [Full Text] [Related]
19. Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists.
Lallemand C; Kavrochorianou N; Steenholdt C; Bendtzen K; Ainsworth MA; Meritet JF; Blanchard B; Lebon P; Taylor P; Charles P; Alzabin S; Tovey MG
J Immunol Methods; 2011 Oct; 373(1-2):229-39. PubMed ID: 21910993
[TBL] [Abstract][Full Text] [Related]
20. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential.
Baron U; Gossen M; Bujard H
Nucleic Acids Res; 1997 Jul; 25(14):2723-9. PubMed ID: 9207017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
